Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
Status:
Unknown status
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy of
Octohydroaminoacridine Succinate tablets and find the optimal dose in patients with mild to
moderate Alzheimer's Disease.